 |
amifampridine phosphate |
|---|---|
| Trade Name | |
| Orphan Indication | Myasthenia gravis Myasthenia gravis |
| USA Market Approval | USA |
| USA Designation Date | 2016-08-31 00:00:00 |
| Sponsor | Catalyst Pharmaceuticals, Inc.;355 Alhambra Circle, Suite 1250;Coral Gables, Florida, 33134 |
Learn more about: